Cargando…
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
OBJECTIVE: Recombinant human erythropoietin (rhEPO) therapy under circumstances of moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a protective cardiac effect beyond the correction of anemia, whose mechanism deserves better elucidation, namely by clarifying the...
Autores principales: | Teixeira, M., Rodrigues-Santos, P., Garrido, P., Costa, E., Parada, B., Sereno, J., Alves, R., Belo, L., Teixeira, F., Santos-Silva, A., Reis, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283962/ https://www.ncbi.nlm.nih.gov/pubmed/22368404 http://dx.doi.org/10.4103/0975-7406.92743 |
Ejemplares similares
-
TBX2 controls a proproliferative gene expression program in melanoma
por: Lu, Sizhu, et al.
Publicado: (2021) -
Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia
por: Garrido, Patrícia, et al.
Publicado: (2015) -
The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats
por: Kim, Moon Sun, et al.
Publicado: (2010) -
Dual Switch Mechanism of Erythropoietin as an Antiapoptotic
and Pro-Angiogenic Determinant in the Retina
por: Samson, Faith Pwaniyibo, et al.
Publicado: (2020) -
Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)